Marx, S O <br/><br/>
Bench to bedside: the development of rapamycin and its application to stent restenosis.  [electronic resource] 

 -  Circulation  Aug 2001 
 - 852-5 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.104.8.852  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Animals<br/>Calcineurin Inhibitors<br/>Carrier Proteins--metabolism<br/>Cell Cycle Proteins--metabolism<br/>Cell Division--drug effects<br/>Cell Movement--drug effects<br/>Clinical Trials as Topic<br/>Clopidogrel<br/>Coronary Artery Disease--surgery<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>Down-Regulation--drug effects<br/>Graft Occlusion, Vascular--diagnosis<br/>Humans<br/>Hyperplasia--diagnosis<br/>Macromolecular Substances<br/>Phosphotransferases (Alcohol Group Acceptor)<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Signal Transduction--drug effects<br/>Sirolimus--metabolism<br/>Stents--adverse effects<br/>TOR Serine-Threonine Kinases<br/>Tacrolimus--pharmacology<br/>Tacrolimus Binding Protein 1A--metabolism<br/>Ticlopidine--analogs & derivatives<br/>Tumor Suppressor Proteins<br/>Tunica Media--drug effects<br/>Vascular Patency--drug effects